Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

This study has been completed.

Study NCT00016107 Information provided by Cancer and Leukemia Group B

First Received: May 6, 2001 Last Updated: March 30, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	February 2007 (Final data collection date for primary outcome measure)

Publications:

Picus J, Halabi S, Rini B, et al.: The use of bevacizumab (B) with docetaxel (D) and estramustine (E) in hormone refractory prostate cancer (HRPC): initial results of CALGB 90006. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-1578, 2003.